Company

Astellas Pharma Appoints Zhao Ping as Chairman of China Operations

CompanyDeals

Keylights Biotechnology Raises $14 Million in Series B to Expand IVD Instrument Range

CompanyDrug

Joincare Pharmaceutical’s Partner Fermion Gets NMPA Green Light for Pain Drug Clinical Study

CompanyDeals

Gansu Deshengtang Partners with RELEX Solutions to Enhance Supply Chain Efficiency

CompanyDrug

GSK Secures Second Indication Approval for Nucala in China for Severe Eosinophilic Asthma

CompanyDeals

China Resources Medical Laboratory Partners with Qlife Lab for Comprehensive Mass Spectrometry Solutions

CompanyDeals

WuXi Biologics Partners with BioNTech to Develop Next-Gen Antibodies in $20 Million Deal

CompanyDeals

Junshi Biosciences Regains Global Rights to JS006 as Coherus Terminates Licensing Agreement

Policy / Regulatory

China’s NHC Unveils Strategy to Enhance Pediatric Healthcare by 2025

CompanyDeals

Amgen Licenses XeriJect Technology from Xeris Biopharma for Subcutaneous Tepezza Development

CompanyDrug

Eli Lilly Secures NMPA Approval for Emgality as Preventive Migraine Treatment in China

Company

C4 Therapeutics Outlines 2024 Focus Amid 30% Workforce Reduction, Prioritizes Key Oncology Trials